Advertisement

Metabolic Syndrome and Atherosclerosis in Nondiabetic Postmenopausal Women

  • Stavroula A. Paschou
  • Panagiotis Anagnostis
  • Dimitrios G. Goulis
  • Irene LambrinoudakiEmail author
Chapter

Abstract

The aim of this chapter is to analyse and critically appraise current knowledge regarding the effect of menopause on metabolic syndrome (MetS) and its components, as well as on the risk of atherosclerosis and cardiovascular disease (CVD). Transition to menopause is characterised by a decrease in oestrogen concentrations, relative androgen excess and a decrease in sex hormone-binding globulin concentrations, which are accompanied by changes in fat tissue distribution and increased prevalence of central obesity, insulin resistance and MetS. Some of the individual components of MetS seem to be affected by menopause per se, such as disorders of glucose metabolism, while some others seem to be the result of increased central obesity and insulin resistance, such as hypertension. The lipid profile worsens during the menopausal transition, but whether this phenomenon is irrespective of age, body mass index and central obesity is inconclusive. The presence of MetS appears to increase the risk of CVD after menopause. Surgical menopause is strongly associated with a higher incidence of MetS and increased risk for CVD. Bearing in mind that most women will spend more than one-third of their lifespan in the menopausal status, public health strategies should encourage women to maintain normal body weight during the transition to post-reproductive life, in an attempt to counteract the consequences of both chronological and ovarian ageing.

Keywords

Menopause Metabolic syndrome Obesity Atherosclerosis Cardiovascular disease 

Notes

Competing Interest

None to declare.

Funding: None.

References

  1. 1.
    Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.PubMedCrossRefGoogle Scholar
  2. 2.
    Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287:356–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP. Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview. Curr Vasc Pharmacol. 2014;12:627–41.PubMedCrossRefGoogle Scholar
  4. 4.
    Paschou SA, Anagnostis P, Goulis DG, Lambrinoudaki I. Androgen excess and post-reproductive health. Maturitas. 2018;115:115–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Tchernof A, Desmeules A, Richard C, et al. Ovarian hormone status and abdominal visceral adipose tissue metabolism. J Clin Endocrinol Metab. 2004;89:3425–30.PubMedCrossRefGoogle Scholar
  6. 6.
    Barrett-Connor E. Menopause, atherosclerosis, and coronary artery disease. Curr Opin Pharmacol. 2013;13:186–91.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Anagnostis P, Stevenson JC, Crook D, Johnston DG, Godsland IF. Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions. Maturitas. 2015;81:62–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Zuo H, Shi Z, Hu X, Wu M, Guo Z, Hussain A. Prevalence of metabolic syndrome and factors associated with its components in Chinese adults. Metabolism. 2009;58:1102–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med. 2003;163:427–36.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Stefanska A, Bergmann K, Sypniewska G. Metabolic syndrome and menopause: pathophysiology, clinical and diagnostic significance. Adv Clin Chem. 2015;72:1–75.PubMedCrossRefGoogle Scholar
  11. 11.
    Khanam MA, Qiu C, Lindeboom W, Streatfield PK, Kabir ZN, Wahlin A. The metabolic syndrome: prevalence, associated factors, and impact on survival among older persons in rural Bangladesh. PLoS One. 2011;6:e20259.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Kwasniewska M, Pikala M, Kaczmarczyk-Chalas K, et al. Smoking status, the menopausal transition, and metabolic syndrome in women. Menopause. 2012;19:194–201.PubMedCrossRefGoogle Scholar
  13. 13.
    Mesch VR, Boero LE, Siseles NO, et al. Metabolic syndrome throughout the menopausal transition: influence of age and menopausal status. Climacteric. 2006;9:40–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Wamala SP, Lynch J, Horsten M, Mittleman MA, Schenck-Gustafsson K, Orth-Gomer K. Education and the metabolic syndrome in women. Diabetes Care. 1999;22:1999–2003.PubMedCrossRefGoogle Scholar
  15. 15.
    Cho GJ, Lee JH, Park HT, et al. Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome. Menopause. 2008;15:524–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Eshtiaghi R, Esteghamati A, Nakhjavani M. Menopause is an independent predictor of metabolic syndrome in Iranian women. Maturitas. 2010;65:262–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Miller AM, Wilbur J, Chandler PJ, Sorokin O. Cardiovascular disease risk factors and menopausal status in midlife women from the former Soviet Union. Women Health. 2003;38:19–36.PubMedCrossRefGoogle Scholar
  18. 18.
    Ziaei S, Mohseni H. Correlation between hormonal statuses and metabolic syndrome in postmenopausal women. J Family Reprod Health. 2013;7:63–6.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Torrens JI, Sutton-Tyrrell K, Zhao X, et al. Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: study of Women’s health across the nation. Menopause. 2009;16:257–64.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Hallajzadeh J, Khoramdad M, Izadi N, et al. Metabolic syndrome and its components in premenopausal and postmenopausal women: a comprehensive systematic review and meta-analysis on observational studies. Menopause. 2018;25(10):1155–64.PubMedCrossRefGoogle Scholar
  21. 21.
    Pu D, Tan R, Yu Q, Wu J. Metabolic syndrome in menopause and associated factors: a meta-analysis. Climacteric. 2017;20:583–91.PubMedCrossRefGoogle Scholar
  22. 22.
    Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab. 2003;88:2404–11.PubMedCrossRefGoogle Scholar
  23. 23.
    Szmuilowicz ED, Stuenkel CA, Seely EW. Influence of menopause on diabetes and diabetes risk. Nat Rev Endocrinol. 2009;5:553–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Ebtekar F, Dalvand S, Gheshlagh RG. The prevalence of metabolic syndrome in postmenopausal women: a systematic review and meta-analysis in Iran. Diabetes Metab Syndr. 2018;12(6):955–60.CrossRefGoogle Scholar
  25. 25.
    Donato GB, Fuchs SC, Oppermann K, Bastos C, Spritzer PM. Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio. Menopause. 2006;13:280–5.PubMedCrossRefGoogle Scholar
  26. 26.
    Svendsen OL, Hassager C, Christiansen C. Age- and menopause associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry. Metabolism. 1995;44:369–37.PubMedCrossRefGoogle Scholar
  27. 27.
    Toth MJ, Tchernof A, Sites CK, Poehlman ET. Effect of menopausal status on body composition and abdominal fat distribution. Int J Obes Relat Metab Disord. 2000;24:226–31.CrossRefGoogle Scholar
  28. 28.
    Lee CG, Carr MC, Murdoch SJ, et al. Adipokines, inflammation, and visceral adiposity across the menopausal transition: a prospective study. J Clin Endocrinol Metab. 2009;94:1104–10.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes. 2008;32:949–58.CrossRefGoogle Scholar
  30. 30.
    Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539–53.PubMedCrossRefGoogle Scholar
  31. 31.
    Lindheim SR, Buchanan TA, Duffy DM, et al. Comparison of estimates of insulin sensitivity in pre- and postmenopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test. J Soc Gynecol Investig. 1994;1:150–4.PubMedCrossRefGoogle Scholar
  32. 32.
    Walton C, Godsland IF, Proudler AJ, Wynn V, Stevenson JC. The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women. Eur J Clin Investig. 1993;23:466–73.CrossRefGoogle Scholar
  33. 33.
    Muscelli E, Kozakova M, Flyvbjerg A, et al. The effect of menopause on carotid artery remodeling, insulin sensitivity, and plasma adiponectin in healthy women. Am J Hypertens. 2009;22:364–70.PubMedCrossRefGoogle Scholar
  34. 34.
    Toth MJ, Sites CK, Eltabbakh GH, Poehlman ET. Effect of menopausal status on insulin-stimulated glucose disposal: comparison of middle-aged premenopausal and early postmenopausal women. Diabetes Care. 2000;23:801–6.PubMedCrossRefGoogle Scholar
  35. 35.
    Yang R, Yang S, Li R, Liu P, Qiao J, Zhang Y. Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis. Reprod Biol Endocrinol. 2016;14:67.PubMedPubMedCentralCrossRefGoogle Scholar
  36. 36.
    Paschou SA, Palioura E, Ioannidis D, Anagnostis P, Panagiotakou A, Loi V, Karageorgos G, Goulis DG, Vryonidou A. Adrenal hyperandrogenism does not deteriorate insulin resistance and lipid profile in women with PCOS. Endocr Connect. 2017;6:601–6.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Kavanagh K, Espeland MA, Sutton-Tyrrell K, Barinas-Mitchell E, El Khoudary SR, Wildman RP. Liver fat and SHBG affect insulin resistance in midlife women: the study of Women’s health across the nation (SWAN). Obesity (Silver Spring). 2013;21:1031–8.CrossRefGoogle Scholar
  38. 38.
    de Kat AC, Dam V, Onland-Moret NC, Eijkemans MJ, et al. Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study. BMC Med. 2017;15:2.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Matthews KA, Crawford SL, Chae CU, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol. 2009;54:2366–73.PubMedPubMedCentralCrossRefGoogle Scholar
  40. 40.
    Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis. 1993;98:83–90.PubMedCrossRefGoogle Scholar
  41. 41.
    Choi Y, Chang Y, Kim BK, et al. Menopausal stages and serum lipid and lipoprotein abnormalities in middle-aged women. Maturitas. 2015;80:399–405.PubMedCrossRefGoogle Scholar
  42. 42.
    Anagnostis P, Stevenson JC, Crook D, Johnston DG, Godsland IF. Effects of gender, age and menopausal status on serum apolipoprotein concentrations. Clin Endocrinol. 2016;85:733–40.CrossRefGoogle Scholar
  43. 43.
    Anagnostis P, Karras S, Lambrinoudaki I, Stevenson JC, Goulis DG. Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options. Int J Clin Pract. 2016;70:967–77.PubMedCrossRefGoogle Scholar
  44. 44.
    Benjamin EJ, Blaha MJ, Chiuve SE, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–603.Google Scholar
  45. 45.
    Zhou Y, Zhou X, Guo X, et al. Prevalence and risk factors of hypertension among pre- and post-menopausal women: a cross-sectional study in a rural area of Northeast China. Maturitas. 2015;80:282–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Stamler J, Stamler R, Riedlinger WF, Algera G, Roberts RH. Hypertension screening of 1 million Americans. Community hypertension evaluation clinic (CHEC) program, 1973 through 1975. JAMA. 1976;235:2299–306.PubMedCrossRefGoogle Scholar
  47. 47.
    Flegal KM, Ogden CL, Carroll MD. Prevalence and trends in overweight in Mexican-American adults and children. Nutr Rev. 2004;62:S144–8.PubMedCrossRefGoogle Scholar
  48. 48.
    Qiuping G, Burt VL, Paulose-Ram R, Charles F. Dillon gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999–2004. Am J Hypertens. 2008;21:789–98.CrossRefGoogle Scholar
  49. 49.
    Lima R, Wofford M, Reckelhoff JF. Hypertension in postmenopausal women. Curr Hypertens Rep. 2012;14:254–60.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Zambrana RE, López L, Dinwiddie GY, Ray RM, Phillips LS, Trevisan M, Wassertheil-Smoller S. Prevalence and incident prehypertension and hypertension in postmenopausal Hispanic women: results from the Women’s Health Initiative. Am J Hypertens. 2014;27:372–81.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Ganguli D, Das N, Saha I, Chaudhuri D, Ghosh S, Dey S. Risk factors for hypertension in a population-based sample of postmenopausal women in Kolkata, West Bengal, India. Asia Pac J Public Health. 2013;25:388–97.PubMedCrossRefGoogle Scholar
  52. 52.
    Ben Ali S, Belfki-Benali H, Ahmed DB, Haddad N, Jmal A, Abdennebi M, Romdhane HB. Postmenopausal hypertension, abdominal obesity, apolipoprotein and insulin resistance. Clin Exp Hypertens. 2016;38:370–4.PubMedCrossRefGoogle Scholar
  53. 53.
    Zanchetti A, Facchetti R, Cesana GC, Modena MG, Pirrelli A, Sega R, SIMONA Participants. Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study. J Hypertens. 2005;23:2269–76.PubMedCrossRefGoogle Scholar
  54. 54.
    Cifkova R, Pitha J, Lejskova M, Lanska V, Zecova S. Blood pressure around the menopause: a population study. J Hypertens. 2008;26:1976–82.PubMedCrossRefGoogle Scholar
  55. 55.
    Coylewright M, Reckelhoff JF, Ouyang P. Menopause and hypertension: an age-old debate. Hypertension. 2008;51:952–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Casiglia E, Tikhonoff V, Caffi S, et al. Menopause does not affect blood pressure and risk profile, and menopausal women do not become similar to men. J Hypertens. 2008;26:1983–92.PubMedCrossRefGoogle Scholar
  57. 57.
    Georgiopoulos GA, Lambrinoudaki I, Athanasouli F, et al. Free androgen index as a predictor of blood pressure progression and accelerated vascular aging in menopause. Atherosclerosis. 2016;247:177–83.PubMedCrossRefGoogle Scholar
  58. 58.
    Lambrinoudaki I, Georgiopoulos GA, Athanasouli F, et al. Free androgen index as a determinant of arterial stiffness in menopause: a mediation analysis. Menopause. 2017;24:635–44.PubMedCrossRefGoogle Scholar
  59. 59.
    Otsuki M, Kasayama S, Morita S, et al. Menopause, but not age, is an independent risk factor for fasting plasma glucose levels in nondiabetic women. Menopause. 2007;14:404–7.PubMedCrossRefGoogle Scholar
  60. 60.
    Matthews KA, Gibson CJ, El Khoudary SR, Thurston RC. Changes in cardiovascular risk factors by hysterectomy status with and without oophorectomy: study of Women’s health across the nation. J Am Coll Cardiol. 2013;62:191–200.PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    Park SK, Harlow SD, Zheng H, et al. Association between changes in oestradiol and follicle-stimulating hormone levels during the menopausal transition and risk of diabetes. Diabet Med. 2017;34:531–8.PubMedPubMedCentralCrossRefGoogle Scholar
  62. 62.
    Brand JS, van der Schouw YT, Onland-Moret NC, et al. Age at menopause, reproductive life span, and type 2 diabetes risk: results from the EPIC-InterAct Study. Diabetes Care. 2013;36:1012–9.PubMedPubMedCentralCrossRefGoogle Scholar
  63. 63.
    Shen L, Song L, Li H, et al. Association between earlier age at natural menopause and risk of diabetes in middle-aged and older Chinese women: the Dongfeng-Tongji cohort study. Diabetes Metab. 2017;43:345–50.PubMedCrossRefGoogle Scholar
  64. 64.
    Appiah D, Winters SJ, Hornung CA. Bilateral oophorectomy and the risk of incident diabetes in postmenopausal women. Diabetes Care. 2014;37:725–33.PubMedCrossRefGoogle Scholar
  65. 65.
    LeBlanc ES, Kapphahn K, Hedlin H, et al. Reproductive history and risk of type 2 diabetes mellitus in postmenopausal women: findings from the Women’s Health Initiative. Menopause. 2017;24:64–72.PubMedPubMedCentralCrossRefGoogle Scholar
  66. 66.
    Moreau KL, Hildreth KL, Meditz AL, Deane KD, Kohrt WM. Endothelial function is impaired across the stages of the menopause transition in healthy women. J Clin Endocrinol Metab. 2012;97:4692–700.PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med. 1976;85:447–52.PubMedCrossRefGoogle Scholar
  68. 68.
    Tao XY, Zuo AZ, Wang JQ, Tao FB. Effect of primary ovarian insufficiency and early natural menopause on mortality: a meta-analysis. Climacteric. 2016;19:27–36.PubMedCrossRefGoogle Scholar
  69. 69.
    Roeters van Lennep JE, Heida KY, Bots ML, Hoek A. Cardiovascular disease risk in women with premature ovarian insufficiency: a systematic review and meta-analysis. Eur J Prev Cardiol. 2016;23:178–86.PubMedCrossRefGoogle Scholar
  70. 70.
    Muka T, Oliver-Williams C, Kunutsor S, et al. Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis. JAMA Cardiol. 2016;1:767–76.PubMedCrossRefGoogle Scholar
  71. 71.
    Colditz GA, Willett WC, Stampfer MJ, et al. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316:1105–10.PubMedCrossRefGoogle Scholar
  72. 72.
    Atsma F, Bartelink ML, Grobbee DE, van der Schouw YT. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause. 2006;13:265–79.PubMedCrossRefGoogle Scholar
  73. 73.
    Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ 3rd. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol. 2006;7:821–8.PubMedCrossRefGoogle Scholar
  74. 74.
    Mikkola TS, Gissler M, Merikukka M, Tuomikoski P, Ylikorkala O. Sex differences in age-related cardiovascular mortality. PLoS One. 2013;8:e63347.PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Lambrinoudaki I, Kazani A, Armeni E, et al. The metabolic syndrome is associated with carotid atherosclerosis and arterial stiffness in asymptomatic, nondiabetic postmenopausal women. Gynecol Endocrinol. 2018;34:78–82.PubMedCrossRefGoogle Scholar
  76. 76.
    Lambrinoudaki I, Kazani MV, Armeni E, et al. The TyG index as a marker of subclinical atherosclerosis and arterial stiffness in lean and overweight postmenopausal women. Heart Lung Circ. 2018;27:716–24.PubMedCrossRefGoogle Scholar
  77. 77.
    Stamatelopoulos KS, Armeni E, Georgiopoulos G, et al. Recently postmenopausal women have the same prevalence of subclinical carotid atherosclerosis as age and traditional risk factor matched men. Atherosclerosis. 2012;221:508–13.PubMedCrossRefGoogle Scholar
  78. 78.
    Soleimani A, Pourmoghaddas A, Sadeghi M, et al. Risk and age of cardiovascular event in women with metabolic syndrome: menopause age in focus. Metab Syndr Relat Disord. 2018;16:127–34.PubMedCrossRefGoogle Scholar
  79. 79.
    van Herpt TT, Dehghan A, van Hoek M, et al. The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: the Rotterdam study. Cardiovasc Diabetol. 2016;15:69.PubMedPubMedCentralCrossRefGoogle Scholar
  80. 80.
    Lambrinoudaki I, Armeni E, Georgiopoulos G, et al. Subclinical atherosclerosis in menopausal women with low to medium calculated cardiovascular risk. Int J Cardiol. 2013;164:70–6.PubMedCrossRefGoogle Scholar
  81. 81.
    Creatsa M, Armeni E, Stamatelopoulos K, et al. Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women. Metabolism. 2012;61:193–201.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Stavroula A. Paschou
    • 1
  • Panagiotis Anagnostis
    • 2
  • Dimitrios G. Goulis
    • 3
  • Irene Lambrinoudaki
    • 4
    Email author
  1. 1.Division of Endocrinology and Diabetes“Aghia Sophia” Hospital, Medical School, National and Kapodistrian University of AthensAthensGreece
  2. 2.Unit of Reproductive Endocrinology, First Department of Obstetrics and Gynaecology, Medical SchoolAristotle University of Thessaloniki, “Papageorgiou” General HospitalThessalonikiGreece
  3. 3.Unit of Reproductive Endocrinology, First Department of Obstetrics and Gynaecology, Medical SchoolAristotle University of ThessalonikiThessalonikiGreece
  4. 4.Division of Endocrinology and Diabetes, Second Department of Obstetrics and Gynaecology, Medical SchoolNational and Kapodistrian University of AthensAthensGreece

Personalised recommendations